The BioCentury 100 index rocketed 392.6 points (19 percent) to 2417.81 on Monday, the first day of the Chase H&Q Healthcare Conference, with genomics frenzy pacing the sector. Big winners included Genome Therapeutics (GENE), up...
Gene Logic Inc. Columbia, Md. Technology: Accelerated Target Discovery platform centered on READS system (Restriction Enzyme Analysis of Differentially expressed Sequences) Disease focus: Central nervous system disorders; osteoporosis; prostate, breast and colon cancer; heart failure;...
The BioCentury 100 index rocketed 392.6 points (19 percent) to 2417.81 on Monday, the first day of the Chase H&Q Healthcare Conference, with genomics frenzy pacing the sector. Big winners included Genome Therapeutics (GENE), up...
Gene Logic Inc. Columbia, Md. Technology: Accelerated Target Discovery platform centered on READS system (Restriction Enzyme Analysis of Differentially expressed Sequences) Disease focus: Central nervous system disorders; osteoporosis; prostate, breast and colon cancer; heart failure;...